We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+11.75%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$65.7B
AUM Growth
+$6.62B
Cap. Flow
+$648M
Cap. Flow %
0.99%
Top 10 Hldgs %
27.2%
Holding
2,939
New
828
Increased
695
Reduced
744
Closed
553

Top Sells

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$400M
2
STZ icon
Constellation Brands
STZ
+$345M
3
META icon
Meta Platforms (Facebook)
META
+$286M
4
KVUE icon
Kenvue
KVUE
+$277M
5
ABBV icon
AbbVie
ABBV
+$258M

Sector Composition

Rank Sector Weight
1 Technology 16.4%
2 Healthcare 13.22%
3 Consumer Discretionary 12.71%
4 Financials 7.66%
5 Communication Services 7.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GAMB
1776
DELISTED
Gambling.com
GAMB
$695K ﹤0.01%
76,173
+27,918
+58% +$253K
VXRT
1777
DELISTED
Vaxart
VXRT
$693K ﹤0.01%
+533,079
New +$559K
STTK icon
1778
Shattuck Labs
STTK
$651M
$693K ﹤0.01%
+77,495
New +$710K
TRUE
1779
DELISTED
TrueCar
TRUE
$691K ﹤0.01%
+203,859
New +$707K
NVGS icon
1780
Navigator Holdings
NVGS
$1.34B
$689K ﹤0.01%
44,879
-64,429
-59% -$993K
CUK
1781
DELISTED
Carnival PLC
CUK
$688K ﹤0.01%
+46,700
New +$691K
HLLY.WS
1782
CALL
DELISTED
Holley Inc Warrants
HLLY.WS
$686K ﹤0.01%
173,638
-1,362
-0.8% -$530
TFII icon
1783
TFI International
TFII
$12.1B
$683K ﹤0.01%
+4,285
New +$613K
IGMS
1784
DELISTED
IGM Biosciences
IGMS
$683K ﹤0.01%
+70,776
New +$820K
ELEV
1785
DELISTED
Elevation Oncology
ELEV
$681K ﹤0.01%
+132,696
New +$430K
ESGE icon
1786
iShares ESG Aware MSCI EM ETF
ESGE
$6.41B
$681K ﹤0.01%
+21,118
New +$665K
HLI icon
1787
Houlihan Lokey
HLI
$10.2B
$679K ﹤0.01%
+5,300
New +$656K
GAU
1788
Galiano Gold
GAU
$455M
$679K ﹤0.01%
+485,218
New +$493K
TMFC icon
1789
Motley Fool 100 Index ETF
TMFC
$2.01B
$678K ﹤0.01%
+13,666
New +$648K
CSPI icon
1790
CSP Inc
CSPI
$81.9M
$676K ﹤0.01%
+36,600
New +$586K
YEXT icon
1791
Yext
YEXT
$564M
$671K ﹤0.01%
111,265
-167,416
-60% -$990K
IONS icon
1792
Ionis Pharmaceuticals
IONS
$9.14B
$669K ﹤0.01%
15,443
-118,106
-88% -$5.63M
UNFI icon
1793
United Natural Foods
UNFI
$3.07B
$667K ﹤0.01%
58,081
-63,231
-52% -$919K
SXT icon
1794
Sensient Technologies
SXT
$5.3B
$663K ﹤0.01%
+9,576
New +$621K
KD icon
1795
Kyndryl
KD
$2.94B
$662K ﹤0.01%
+30,422
New +$647K
MCB icon
1796
Metropolitan Bank Holding Corp
MCB
$1.14B
$661K ﹤0.01%
+17,179
New +$752K
XLY icon
1797
CALL
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$21.9B
$661K ﹤0.01%
7,400
-403,200
-98% -$35.9M
OEF icon
1798
iShares S&P 100 ETF
OEF
$19.8B
$659K ﹤0.01%
+2,663
New +$628K
RCKY icon
1799
Rocky Brands
RCKY
$322M
$658K ﹤0.01%
24,269
-4,049
-14% -$111K
AXON
1800
Axon Enterprise
AXON
$44.1B
$657K ﹤0.01%
2,100
-1,000
-32% -$278K

Similar funds

Marshall Wace's Q1 2024 Portfolio in Review

As of Q1 2024, Marshall Wace held 2,939 positions worth $65.7B, up 11% from $59B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Marshall Wace's Q1 2024 filing shows 828 new, 695 increased, 744 reduced and 553 closed positions. Its largest new stake was Vanguard S&P 500 ETF: 900,000 shares worth $433M. The largest sale was Walmart Inc, an estimated $400M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Marshall Wace's largest Q1 2024 buy was Vanguard S&P 500 ETF: 900,000 shares worth $433M.
  • Marshall Wace added most to Goldman Sachs in Q1 2024, an estimated $374M increase.
  • Marshall Wace's biggest Q1 2024 reduction was Walmart Inc, cutting an estimated $400M.
  • Marshall Wace fully exited Celsius Holdings in Q1 2024, selling an estimated $143M.
  • Marshall Wace's ten largest holdings make up 27% of its $65.7B portfolio in Q1 2024.
  • Marshall Wace opened 828 new positions and closed 553 in Q1 2024.
  • Marshall Wace's portfolio value rose 11% quarter-over-quarter to $65.7B.

Based on Marshall Wace's 13F filing for Q1 2024, filed 15 May 2024.